ArticlePatient preference and adherence2022

Patient Satisfaction with Once-Daily Single-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (DRV/c/FTC/TAF): A Real-World Study of Patient Self-Reported Outcomes in HIV-1-Diagnosed Adults.

Joyce LaMori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.